Showing results (151-160 of 1,026) with videos related to

Sort By:
Pageof 103
Journal of Neuro-Oncology|November 10, 2022
CRISPR/Cas9-mediated abrogation of CD95L/CD95 signaling-induced glioma cell growth and immunosuppression increases survival in murine glioma modelsClara Quijano-Rubio, Manuela Silginer, Michael Weller
Glia|February 5, 2011
Isocitrate dehydrogenase mutations: a challenge to traditional views on the genesis and malignant progression of gliomasMichael Weller, Wolfgang Wick, Andreas von Deimling
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Current State of Immune-Based Therapies for GlioblastomaMichael Lim, Michael Weller, E Antonio Chiocca
Expert Opinion on Therapeutic Targets|January 23, 2021
A vasculature-centric approach to developing novel treatment options for glioblastomaHans-Georg Wirsching, Patrick Roth, Michael Weller
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 19, 2004
Accelerated postoperative radiotherapy with weekly concomitant boost in patients with locally advanced head and neck cancerAbderrahim Zouhair, David Azria, Philippe Pasche, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2005
Perfusion and diffusion MRI of glioblastoma progression in a four-year prospective temozolomide clinical trialAntoine Leimgruber, Sandrine Ostermann, Eun Jo Yeon, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2018
Diagnostic value of 18F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary siteFabian Wolpert, Michael Weller, Anna Sophie Berghoff, et al.
The New England Journal of Medicine|March 11, 2005
MGMT gene silencing and benefit from temozolomide in glioblastomaMonika E Hegi, Annie-Claire Diserens, Thierry Gorlia, et al.
Cancer|September 25, 2004
Can we afford to add chemotherapy to radiotherapy for glioblastoma multiforme? Cost-identification analysis of concomitant and adjuvant treatment with temozolomide until patient deathJean-Blaise Wasserfallen, Sandrine Ostermann, Alessia Pica, et al.
Chinese Clinical Oncology|June 13, 2021
The impact of the molecular classification of glioblastoma on the interpretation of therapeutic clinical trial resultsLauren S Singer, Alexander Z Feldman, Robin A Buerki, et al.
Pageof 103